Source abstract
Abstract
A colorimetric immunoassay is a powerful tool for detecting tumor markers, with outstanding advantages of visualization and convenience. This study designed a colorimetric immunoassay using the antibody/antigen to control the catalytic activity to be “switched on/off”. This system, where Au NPs (18.5 ± 3.9 nm) were loaded on the g-C 3 N 4 nanosheets that were fixed in a three-dimensional porous cellulose hydrogel, was used as a binding site for the antibody/antigen. After being incubated with an antibody of a cancer marker, the turned-off catalytic sites on Au NPs in Au@g-C 3 N 4 /microcrystalline cellulose hydrogels would not be “turned on” until the corresponding antigen was added. The number of the recovered Au active sites was related to the amount of the antigen added. The Fourier transform infrared and X-ray photoelectron spectroscopy measurements did not detect the existence of Au–S bonds. Catalyzed by the turned-on Au NPs, 4-nitrophenol was reduced to 4-aminophenol accompanied by a color fading. The color and the absorption spectrum changes in the process were used as the colorimetric quantitative basis for immunoassays. The colorimetric immunoassay showed a linear relationship with the liver cancer marker (α-fetoprotein, AFP) in the range of 0.1–10 000 ng/mL with the detection limit of 0.46 ng/mL. In addition, 4-nitrophenol had a significant color fading when the AFP concentration exceeded the healthy human threshold. The clinical patient’s serum test results obtained from the developed colorimetric immunosensor were consistent with those obtained from the commercial enzyme-linked immunosorbent assay. Furthermore, the immunosensor exhibited a good selectivity, repeatability, and stability, which demonstrated its potential for practical diagnostic application.
Source: openalex_inverted_index · Quality: baseline
Affiliations
Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, 29 Zhong-guan-cun East Road, Haidian District, Beijing 100190, P. R. China
University of Chinese Academy of Sciences, Beijing 100049, P. R. China
Center of Interventional Oncology and Liver Diseases, Beijing Youan Hospital, Capital Medical University, 08 Xitoutiao, Youwai Street, Fengtai District, Beijing 100069, P. R. China
Funding
National Natural Science Foundation of China · Beijing Youan Hospital · Beijing Municipal Science and Technology Commission · Capital Health Research and Development of Special Fund